Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

Published:2023-10 Issue:10412 Volume:402 Page:1541-1551
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Morita Akimichi,Strober Bruce,Burden A David,Choon Siew Eng,Anadkat Milan J,Marrakchi Slaheddine,Tsai Tsen-Fang,Gordon Kenneth B,Thaçi Diamant,Zheng Min,Hu Na,Haeufel Thomas,Thoma Christian,Lebwohl Mark G

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Impact of generalized pustular psoriasis from the perspective of people living with the condition: results of an online survey;Reisner;Am J Clin Dermatol,2022

2. Clinical course and characteristics of generalized pustular psoriasis;Choon;Am J Clin Dermatol,2022

3. The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review;Kharawala;Expert Rev Clin Immunol,2020

4. Drug survival in the treatment of generalized pustular psoriasis: a retrospective multicenter study;Kromer;Dermatol Ther,2021

5. Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis;Iznardo;Br J Dermatol,2021

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in Psoriasis;Dermatologic Clinics;2024-09

2. Real-world use of spesolimab for the treatment of generalized pustular psoriasis: reports from four cases;Journal of Dermatology for Physician Assistants;2024-08-21

3. Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab;JAMA Dermatology;2024-08-07

4. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search;Dermatology and Therapy;2024-08-01

5. Spesolimab use in generalised pustular psoriasis flares;The Lancet;2024-08